Morgan Stanley’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-26,967
| Closed | -$3.55M | – | 7708 |
|
|
2020
Q4 | $3.55M | Buy |
26,967
+24,865
| +1,183% | +$3.27M | ﹤0.01% | 3634 |
|
|
2020
Q3 | $106K | Sell |
2,102
-2,508
| -54% | -$126K | ﹤0.01% | 5408 |
|
|
2020
Q2 | $219K | Buy |
4,610
+1,304
| +39% | +$61.9K | ﹤0.01% | 5036 |
|
|
2020
Q1 | $162K | Sell |
3,306
-33,530
| -91% | -$1.64M | ﹤0.01% | 4959 |
|
|
2019
Q4 | $2.11M | Buy |
36,836
+22,022
| +149% | +$1.26M | ﹤0.01% | 3996 |
|
|
2019
Q3 | $532K | Buy |
14,814
+14,589
| +6,484% | +$524K | ﹤0.01% | 4657 |
|
|
2019
Q2 | $7K | Sell |
225
-2,204
| -91% | -$68.6K | ﹤0.01% | 6253 |
|
|
2019
Q1 | $57K | Sell |
2,429
-8,746
| -78% | -$205K | ﹤0.01% | 5614 |
|
|
2018
Q4 | $154K | Sell |
11,175
-349
| -3% | -$4.81K | ﹤0.01% | 5388 |
|
|
2018
Q3 | $115K | Buy |
11,524
+2,524
| +28% | +$25.2K | ﹤0.01% | 5646 |
|
|
2018
Q2 | $183K | Buy |
+9,000
| New | +$183K | ﹤0.01% | 5570 |
|